An Awake Contralateral, Transcallosal Approach for Deep-Seated Gliomas of the Basal Ganglia. 2019

Robert G Briggs, and Cameron E Nix, and Andrew K Conner, and Ali H Palejwala, and Adam D Smitherman, and Charles Teo, and Michael E Sughrue
Department of Neurosurgery, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, USA.

BACKGROUND The basal ganglia and thalamus are uncommon locations for infiltrating gliomas. Tumors here are usually managed with biopsy and adjuvant therapy, with relatively poor results. Rarely do patients undergo extensive surgical intervention. It seems reasonable to suggest that successful cytoreduction may help these patients. However, this hypothesis has not been studied because of the general view that it is not possible to remove deep-seated brain tumors with acceptable outcomes. METHODS Through retrospective data collection, we describe a small case series of patients undergoing awake contralateral, transcallosal surgery for deep-seated brain tumors affecting the basal ganglia. We describe our patient cohort, report on patient outcomes, and describe our surgical technique. RESULTS Four patients underwent awake contralateral, transcallosal surgery for glioblastoma invading the basal ganglia. All 4 patients demonstrated hemibody weakness contralateral to the side of their tumors, with 3 patients confined to wheelchairs at presentation. Their ages ranged from 25 to 64 years. Tumor volumes ranged from 14 to 93 cm3. More than 50% resection of each tumor was achieved during surgery. In 2 cases, approximately 90% resection was achieved. Motor strength improved in 1 patient who presented with hemiplegia. Two patients required ventriculoperitoneal shunting for complications related to hydrocephalus. At the writing of this article, 2 of our patients were still alive, functional, and free of tumor progression. CONCLUSIONS We present the results of our attempts to resect large gliomas infiltrating the basal ganglia in 4 patients. Our technique combined a contralateral, transcallosal approach with awake neuromonitoring. Our results suggest it is possible to remove these tumors with reasonable outcomes.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D003337 Corpus Callosum Broad plate of dense myelinated fibers that reciprocally interconnect regions of the cortex in all lobes with corresponding regions of the opposite hemisphere. The corpus callosum is located deep in the longitudinal fissure. Interhemispheric Commissure,Neocortical Commissure,Callosum, Corpus,Callosums, Corpus,Commissure, Interhemispheric,Commissure, Neocortical,Commissures, Interhemispheric,Commissures, Neocortical,Corpus Callosums,Interhemispheric Commissures,Neocortical Commissures
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D005910 Glioma Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) Glial Cell Tumors,Malignant Glioma,Mixed Glioma,Glial Cell Tumor,Glioma, Malignant,Glioma, Mixed,Gliomas,Gliomas, Malignant,Gliomas, Mixed,Malignant Gliomas,Mixed Gliomas,Tumor, Glial Cell,Tumors, Glial Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001479 Basal Ganglia Large subcortical nuclear masses derived from the telencephalon and located in the basal regions of the cerebral hemispheres. Basal Nuclei,Ganglia, Basal,Basal Nuclear Complex,Ganglion, Basal,Basal Nuclear Complices,Nuclear Complex, Basal,Nuclei, Basal

Related Publications

Robert G Briggs, and Cameron E Nix, and Andrew K Conner, and Ali H Palejwala, and Adam D Smitherman, and Charles Teo, and Michael E Sughrue
June 2013, Neurosurgery,
Robert G Briggs, and Cameron E Nix, and Andrew K Conner, and Ali H Palejwala, and Adam D Smitherman, and Charles Teo, and Michael E Sughrue
June 2015, Journal of cerebrovascular and endovascular neurosurgery,
Robert G Briggs, and Cameron E Nix, and Andrew K Conner, and Ali H Palejwala, and Adam D Smitherman, and Charles Teo, and Michael E Sughrue
December 2023, World neurosurgery,
Robert G Briggs, and Cameron E Nix, and Andrew K Conner, and Ali H Palejwala, and Adam D Smitherman, and Charles Teo, and Michael E Sughrue
January 1999, Critical reviews in neurosurgery : CR,
Robert G Briggs, and Cameron E Nix, and Andrew K Conner, and Ali H Palejwala, and Adam D Smitherman, and Charles Teo, and Michael E Sughrue
August 1989, Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery,
Robert G Briggs, and Cameron E Nix, and Andrew K Conner, and Ali H Palejwala, and Adam D Smitherman, and Charles Teo, and Michael E Sughrue
December 2007, Neurophysiologie clinique = Clinical neurophysiology,
Robert G Briggs, and Cameron E Nix, and Andrew K Conner, and Ali H Palejwala, and Adam D Smitherman, and Charles Teo, and Michael E Sughrue
February 1985, Journal of neurosurgery,
Robert G Briggs, and Cameron E Nix, and Andrew K Conner, and Ali H Palejwala, and Adam D Smitherman, and Charles Teo, and Michael E Sughrue
October 1996, Neurosurgery,
Robert G Briggs, and Cameron E Nix, and Andrew K Conner, and Ali H Palejwala, and Adam D Smitherman, and Charles Teo, and Michael E Sughrue
October 2021, Brain tumor research and treatment,
Robert G Briggs, and Cameron E Nix, and Andrew K Conner, and Ali H Palejwala, and Adam D Smitherman, and Charles Teo, and Michael E Sughrue
December 2020, World neurosurgery,
Copied contents to your clipboard!